Phage display technology: Clinical applications and recent innovations

Clinical Biochemistry

Volumn 35, Issue 6, 2002, Pages 425-445

  Azzazy, Hassan M E ^a   Highsmith Jr, W Edward ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Bispecific antibodies; Immuno diagnostics; Panning; Phage display; Phage peptide; Recombinant antibodies; Single chain variable fragments

Indexed keywords

ALKALINE PHOSPHATASE; ANTIBODY; ANTIGEN; CANCER ANTIBODY; FLUORESCEIN ISOTHIOCYANATE; HYBRID PROTEIN; IMMUNOGLOBULIN F(AB) FRAGMENT; M PROTEIN; MONOCLONAL ANTIBODY; PEPTIDE DERIVATIVE; PEPTIDE LIBRARY; PRION PROTEIN; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY;

ANTIBODY COMBINING SITE; ANTIBODY ENGINEERING; ANTIBODY ISOLATION; ANTIBODY LIBRARY; ANTIBODY SPECIFICITY; ANTIBODY STRUCTURE; ANTIGEN BINDING; ANTIGEN DETECTION; ANTIGEN RECOGNITION; ANTINEOPLASTIC ACTIVITY; BACTERIOPHAGE; BINDING AFFINITY; BLOOD ANALYSIS; CANCER IMMUNOTHERAPY; CELL FUNCTION; CLONING VECTOR; EFFECTOR CELL; EPITOPE MAPPING; EVOLUTION; GENOTYPE; HUMAN; IMMUNOFLUORESCENCE; LIFE CYCLE; MOLECULAR BIOLOGY; MOLECULE; NONHUMAN; PHAGE DISPLAY; PHENOTYPE; PRION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN ISOLATION; REVIEW; RIBOSOME;

ANIMALS; ANTIBODIES; BACTERIOPHAGES; BIOTECHNOLOGY; PEPTIDE LIBRARY;

EID: 0036753710     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(02)00343-0     Document Type: Review

References (165)

1. Smith G.P. Filamentous fusion phage novel expression vectors that display cloned antigens on the virion surface . Science. 228:1985;1315-1317.
2. Barbas C.F. 3rd. Recent advances in phage display. Curr Opin Biotechnol. 4:1993;526-530.
3. Griffiths A.D. Production of human antibodies using bacteriophage. Curr Opin Immunol. 5:1993;263-267.
4. Winter G., Griffiths A.D., Hawkins R.E., Hoogenboom H.R. Making antibodies by phage display technology. Annu Rev Immunol. 12:1994;433-455.
5. Burton D.R. Phage display. Immunotechnology. 1:1995;87-94.
6. Ladner R.C. Constrained peptides as binding entities. Trends Biotechnol. 13:1995;426-430.
7. Neri D., Petrul H., Roncucci G. Engineering recombinant antibodies for immunotherapy. Cell Biophys. 27:1995;47-61.
8. Hoogenboom H.R., de Bruine A.P., Hufton S.E., Hoet R.M., Arends J.W., Roovers R.C. Antibody phage display technology and its applications. Immunotechnology. 4:1998;1-20.
9. Ladner R.C. Phage display and pharmacogenomics. Pharmacogenomics. 1:2000;199-202.
10. Siegel D.L. Research and clinical applications of antibody phage display in transfusion medicine. Transfus Med Rev. 15:2001;35-52.
11. Cesareni G. Peptide display on filamentous phage capsids. A new powerful tool to study protein-ligand interaction. FEBS Lett. 307:1992;66-70.
12. Better M., Chang C.P., Robinson R.R., Horwitz A.H. Escherichia coli secretion of an active chimeric antibody fragment. Science. 240:1988;1041-1043.
13. Skerra A., Plückthun A. Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. Science. 240:1988;1038-1041.
14. Fuchs P., Breitling F., Dubel S., Seehaus T., Little M. Targeting recombinant antibodies to the surface of Escherichia coli fusion to a peptidoglycan associated lipoprotein . Biotechnology (N Y). 9:1991;1369-1372.
15. Boder E.T., Wittrup K.D. Yeast surface display for screening combinatorial polypeptide libraries. Nat Biotechnol. 15:1997;553-557.
16. Cull M.G., Miller J.F., Schatz P.J. Screening for receptor ligands using large libraries of peptides linked to the C terminus of the lac repressor. Proc Natl Acad Sci U S A. 89:1992;1865-1869.
17. Russel M. Filamentous phage assembly. Mol Microbiol. 5:1991;1607-1613.
18. Dente L., Cesareni G., Micheli G., et al. Monoclonal antibodies that recognize filamentous phage tools for phage display technology . Gene. 148:1994;7-13.
19. Mead D.A., Kemper B. Chimeric single-stranded DNA phage-plasmid cloning vectors. Biotechnology. 10:1988;85-102.
20. Harlow E., Lane D. Antibodies: a laboratory manual. 1988;Cold Spring Harbor Laboratory, New York.
21. Padlan E.A. Anatomy of the antibody molecule. Mol Immunol. 31:1994;169-217.
22. Barbas C.F., Kang A.S., Lerner R.A., Benkovic S.J. Assembly of combinatorial antibody libraries on phage surfaces The gene III site . Proc Natl Acad Sci USA. 88:1991;7978-7981.
23. Griffiths A.D., Williams S.C., Hartley O., et al. Isolation of high affinity human antibodies directly from large synthetic repertoires. EMBO. 13:1994;3245-3260.
24. Waterhouse P., Griffiths A.D., Johnson K.S., Winter G. Combinatorial infection and in vivo recombination a strategy for making large phage antibody repertoires . Nucleic Acids Res. 21:1993;2265-2266.
25. Nissim A., Hoogenboom H.R., Tomlinson I.M., et al. Antibody fragments from a 'single pot' phage display library as immunochemical reagents. EMBO. 13:1994;692-698.
26. Vaughan T.J., Williams A.J., Pritchard K., et al. Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library. Nat Biotechnol. 14:1996;309-314.
27. Yang X.D., Jia X.C., Corvalan J.R., Wang P., Davis C.G., Jakibovits A. Eradication of established tumors by a fully human monoclonal antibody to the epidermal growth factor receptor without concomitant chemotherapy. Cancer Res. 59:1999;1236-1243.
28. Clackson T., Hoogenboom H.R., Griffiths A.D., Winter G. Making antibody fragments using phage display libraries. Nature. 352:1991;624-628.
29. Chester K.A., Begent R.H., Robson L., et al. Phage libraries for generation of clinically useful antibodies. Lancet. 343:1994;455-456.
30. Popov S., Hubbard J.G., Ward E.S. A novel, and efficient route for the isolation of antibodies that recognise T cell receptor V alpha(s). Mol Immunol. 33:1996;493-502.
31. Andersen P.S., Stryhn A., Hansen B.E., Fugger L., Engberg J., Buus S. A recombinant antibody with the antigen-specific, major histocompatibility complex-restricted specificity of T cells. Proc Natl Acad Sci. 93:1996;1820-1824.
32. Yamanaka H.I., Inoue T., Ikeda-Tanaka O. Chicken monoclonal antibody isolated by a phage display system. J Immunol. 157:1996;1156-1162.
33. Lang I.M., Barbas C.F. 3rd, Schleef R.R. Recombinant rabbit Fab with binding activity to type-1 plasminogen activator inhibitor derived from a phage-display library against human alpha-granules. Gene. 172:1996;295-298.
34. Charlton K., Harris W.J., Porter A.J. The isolation of super-sensitive anti-hapten antibodies from combinatorial antibody libraries derived from sheep. Biosens Bioelectron. 16:2001;639-646.
35. Tordsson J.M., Ohlsson L.G., Abrahmsen L.B., Karlstrom P.J., Lando P.A., Brodin T.N. Phage-selected primate antibodies fused to superantigens for immunotherapy of malignant melanoma. Cancer Immunol Immunother. 48:2000;691-702.
36. Cai X., Garen A. Anti-melanoma antibodies from melanoma patients immunized with genetically modified autologous tumor cells selection of specific antibodies from single-chain Fv fusion phage libraries . Proc Natl Acad Sci. 92:1995;6537-6541.
37. Chothia C., Lesk A.M. Canonical structures for the hypervariable regions of immunoglobulins. J Mol Biol. 196:1987;901-917.
38. Sanz I. Multiple mechanisms participate in the generation of diversity of human H chain CDR3 regions. J Immunol. 147:1991;1720-1729.
39. Akamatsu Y., Cole M.S., Tso J.Y., Tsurushita N. Construction of a human Ig combinatorial library from genomic V segments and synthetic CDR3 fragments. J Immunol. 151:1993;4651-4659.
40. Garrard L.J., Henner D.J. Selection of an anti-IGF-1 Fab from a Fab phage library created by mutagenesis of multiple CDR loops. Gene. 128:1993;103-109.
41. McCafferty J., Griffiths A.D., Winter G., Chiswell D.J. Phage antibodies filamentous phage displaying antibody variable domains . Nature. 348:1990;552-554.
42. Marks J.D., Hoogenboom H.R., Bonnert T.P., McCafferty J., Griffiths A.D., Winter G. By-passing immunization. Human antibodies from V-gene libraries displayed on phage. J Mol Biol. 222:1991;581-597.
43. Kang A.S., Barbas C.F., Janda K.D., Benkovic S.J., Lerner R.A. Linkage of recognition and replication functions by assembling combinatorial antibody Fab libraries along phage surfaces. Proc Natl Acad Sci USA. 88:1991;4363-4366.
44. Malmborg A.C., Duenas M., Ohlin M., Soderlind E., Borrebaeck C.A. Selection of binders from phage displayed antibody libraries using the BIAcore biosensor. J Immunol Methods. 198:1996;51-57.
45. Sanna P.P., Williamson R.A., De Logu A., Bloom F.E., Burton D.R. Directed selection of recombinant human monoclonal antibodies to herpes simplex virus glycoproteins from phage display libraries. Proc Natl Acad Sci U S A. 92:1995;6439-6443.
46. Roberts B.L., Markland W., Siranosian K., Saxena M.J., Guterman S.K., Ladner R.C. Protease inhibitor display M13 phage selection of high-affinity neutrophil elastase inhibitors . Gene. 121:1992;9-15.
47. Ward R.L., Clark M.A., Lees J., Hawkins N.J. Retrieval of human antibodies from phage-display libraries using enzymatic cleavage. J Immunol Methods. 189:1996;73-82.
48. Hawkins R.E., Russell S.J., Winter G. Selection of phage antibodies by binding affinity. Mimicking affinity maturation. J Mol Biol. 226:1992;889-896.
49. de Kruif J., Terstappen L., Boel E., Logtenberg T. Rapid selection of cell subpopulation-specific human monoclonal antibodies from a synthetic phage antibody library. Proc Natl Acad Sci U S A. 92:1995;3938-3942.
50. Siegel D.L., Chang T.Y., Russell S.L., Bunya V.Y. Isolation of cell surface-specific human monoclonal antibodies using phage display and magnetically-activated cell sorting applications in immunohematology . J Immunol Methods. 206:1997;73-85.
51. Kupsch J.M., Tidman N.H., Kang N.V., et al. Isolation of human tumor-specific antibodies by selection of an antibody phage library on melanoma cells. Clin Cancer Res. 5:1999;925-931.
52. Pasqualini R., Ruoslahti E. Organ targeting in vivo using phage display peptide libraries. Nature. 380:1996;364-366.
53. de Bruin R., Spelt K., Mol J., Koes R., Quattrocchio. Selection of high-affinity phage antibodies from phage display libraries. Nat Biotech. 17:1999;397-399.
54. Kipriyanov S.M., Moldenhauer G., Little M. High level production of soluble single chain antibodies in small-scale Escherichia coli cultures. J Immunol Methods. 200:1997;69-77.
55. Mavrangelos C., Thiel M., Adamson P.J., et al. Increased Yield and Activity of Soluble Single-Chain Antibody Fragments by Combining High-Level Expression and the Skp Periplasmic Chaperonin. Protein Expr Purif. 23:2001;289-295.
56. Sanchez L., Ayala M., Freyre F., et al. High cytoplasmic expression in E. coli, purification, and in vitro refolding of a single chain Fv antibody fragment against the hepatitis B surface antigen. J Biotechnol. 72:1999;13-20.
57. Holliger P., Winter G. Engineering bispecific antibodies. Curr Opin Biotechnol. 4:1993;446-449.
58. Low N.M., Holliger P.H., Winter G. Mimicking somatic hypermutation affinity maturation of antibodies displayed on bacteriophage using a bacterial mutator strain . J Mol Biol. 260:1996;359-368.
59. Crameri A., Cwirla S., Stemmer W.P. Construction and evolution of antibody-phage libraries by DNA shuffling. Nat Med. 2:1996;100-102.
60. Dall'Acqua W., Carter P. Antibody engineering. Curr Opin Struct Biol. 8:1998;443-450.
61. Atwell J.L., Breheney K.A., Lawrence L.J., McCoy A.J., Kortt A.A., Hudson P.J. scFv multimers of the anti-neuraminidase antibody NC10 length of the linker between VH, and VL domains dictates precisely the transition between diabodies, and triabodies . Protein Eng. 12:1999;597-604.
62. Le Gall F., Kipriyanov S.M., Moldenhauer G., Little M. Di-, tri-, and tetrameric single chain Fv antibody fragments against human CD19 effect of valency on cell binding . FEBS Lett. 453:1999;164-168.
63. George A.J., Titus J.A., Jost C.R., et al. Redirection of T cell-mediated cytotoxicity by a recombinant single-chain Fv molecule. J Immunol. 152:1994;1802-1811.
64. Mallender W.D., Voss E.W. Jr. Construction, expression, and activity of a bivalent bispecific single-chain antibody. J Biol Chem. 269:1994;199-206.
65. Balint R.F., Larrick J.W. Antibody engineering by parsimonious mutagenesis. Gene. 137:1993;109-118.
66. Marks J.D., Griffiths A.D., Malmqvist M., Clackson T.P., Bye J.M., Winter G. By-passing immunization building high affinity human antibodies by chain shuffling . Biotechnology (NY). 10:1992;779-783.
67. Schier R., Bye J., Apell G., et al. Isolation of high-affinity monomeric human anti-c-erbB-2 single chain Fv using affinity-driven selection. J Mol Biol. 255:1996;28-43.
68. Smith G.P. Surface presentation of protein epitopes using bacteriophage expression systems. Curr Opin Biotechnol. 2:1991;668-673.
69. Smith G.P., Schultz D.A., Ladbury J.E. A ribonuclease S-peptide antagonist discovered with a bacteriophage display library. Gene. 128:1993;37-42.
70. Greenwood J., Willis A.E., Perham R.N. Multiple display of foreign peptides on a filamentous bacteriophage. Peptides from Plasmodium falciparum circumsporozoite protein as antigens. J Mol Biol. 220:1991;821-827.
71. Felici F., Castagnoli L., Musacchio A., Jappelli R., Cesareni G. Selection of antibody ligands from a large library of oligopeptides expressed on a multivalent exposition vector. J Mol Biol. 222:1991;301-310.
72. Sternberg N., Hoess R.H. Display of peptides and proteins on the surface of bacteriophage lambda. Proc Natl Acad Sci U S A. 92:1995;1609-1613.
73. Scott J.K., Smith G.P. Searching for peptide ligands with an epitope library. Science. 249:1990;386-390.
74. Devlin J.J., Panganiban L.C., Devlin P.E. Random peptide libraries a source of specific protein binding molecules . Science. 249:1990;404-406.
75. Scott J.K., Loganathan D., Easley R.B., Gong X., Goldstein I.J. A family of concanavalin A-binding peptides from a hexapeptide epitope library. Proc Natl Acad Sci U S A. 89:1992;5398-5402.
76. Stephen C.W., Lane D.P. Mutant conformation of p53. Precise epitope mapping using a filamentous phage epitope library. J Mol Biol. 225:1992;577-583.
77. Geysen H.M., Rodda S.J., Mason T.J. A priori delineation of a peptide which mimics a discontinuous antigenic determinant. Mol Immunol. 23:1986;709-715.
78. Smith G.P., Scott J.K. Libraries of peptides and proteins displayed on filamentous phage. Methods Enzymol. 217:1993;228-257.
79. Doorbar J., Winter G. Isolation of a peptide antagonist to the thrombin receptor using phage display. J Mol Biol. 244:1994;361-369.
80. Blank M., Shoenfeld Y., Cabilly S., Heldman Y., Fridkin M., Katchalski-Katzir E. Prevention of experimental antiphospholipid syndrome and endothelial cell activation by synthetic peptides. Proc Natl Acad Sci U S A. 96:1999;5164-5168.
81. Matthews D.J., Wells J.A. Substrate phage selection of protease substrates by monovalent phage display . Science. 260:1993;1113-1117.
82. Ohkubo S., Miyadera K., Sugimoto Y., Matsuo K.i, Wierzba K., Yamada Y. Substrate phage as a tool to identify novel substrate sequences of proteases. Comb Chem High Throughput Screen. 4:2001;573-583.
83. Hill H.R., Stockley P.G. Phage presentation. Mol Microbiol. 20:1996;685-692.
84. Cortese R., Felici F., Galfre G., et al. Epitope discovery using peptide libraries displayed on phage. Trends Biotech. 12:1994;262-267.
85. Lerner R.A., Benkovic S.J., Schultz P.G. At the cross-roads of chemistry and immunology. catalytic antibodies. Science. 252:1991;659-667.
86. Janda K.D., Lo C.-H., Li T., et al. Direct selection for a catalytic mechanism from combinatorial antibody libraries. Proc Natl Acad Sci. 91:1994;2532-2536.
87. Roberts B.L., Markland W., Ley A.C., et al. Directed evolution of a protein selection of potent neutrophil elastase inhibitors displayed on M13 fusion phage . Proc Natl Acad Sci. 89:1992;2429-2433.
88. Valuev V.P., Afonnikov D.A., Ponomarenko M.P., Milanesi L., Kolchanov N.A. ASPD (Artificially Selected Proteins/Peptides Database) a database of proteins, and peptides evolved in vitro . Nucleic Acids Res. 30:2002;200-202.
89. McCafferty J., Jackson R.H., Chiswell D.J. Phage enzymes expression and affinity chromatography of functional alkaline phosphatase on the surface of bacteriophage . Prot Eng. 4:1991;955-961.
90. Corey D.R., Shiau A.K., Yang Q., et al. Trypsin display on the surface of bacteriophage. Gene. 128:1993;129-134.
91. Siemers N.O., Yelton D.E., Bajorath J., et al. Modifying the specificity and activity of the Enterobacter cloacae P99 β-lactamase by mutagenesis within an M13 phage vector. Biochemistry. 35:1996;2104-2111.
92. Kobatake E., Sasakura H., Haruyama T., Laukkanen M.L., Keinanen K., Aizawa M.A. Fluoroimmunoassay based on immunoliposomes containing genetically engineered lipid-tagged antibody. Anal Chem. 69:1997;1295-1298.
93. Harper K., Kerschbaumer R.J., Ziegler A., et al. A scFv-alkaline phosphatase fusion protein which detects potato leafroll luteovirus in plant extracts by ELISA. J Virol Methods. 63:1997;237-242.
94. Mandecki W., Shallcross M.A., Sowadski J., Tomazic-Allen S. Mutagenesis of conserved residues within the active site of Escherichia coli alkaline phosphatase yields enzymes with increased kcat. Protein Eng. 4:1991;801-804.
95. Reimann K.A., Waite B.C., Lee-Parritz D.E., et al. Use of human leukocyte-specific monoclonal antibodies for clinically immunophenotyping lymphocytes of rhesus monkeys. Cytometry. 17:1994;102-108.
96. Griep R.A., van Twisk C., van der Wolf J.M., Schots A. Fluobodies green fluorescent single-chain Fv fusion proteins . J Immunol Methods. 230:1999;121-130.
97. Felici F., Galfre G., Luzzago A., Monaci P., Nicosia A., Cortese R. Phage-displayed peptides as tools for characterization of human sera. Methods Enzymol. 267:1996;116-129.
98. Folgori A., Luzzago A., Monaci P., Nicosia A., Cortese R., Felici F. Identification of disease-specific epitopes. Methods Mol Biol. 87:1998;195-208.
99. Minenkova O., Gargano N., De Tomassi A., et al. ADAM-HCV, a new-concept diagnostic assay for antibodies to hepatitis C virus in serum. Eur J Biochem. 268:2001;4758-4768.
100. Tam J.P. Synthetic peptide vaccine design synthesis and properties of a high-density multiple antigenic peptide system . Proc Natl Acad Sci U S A. 85:1988;5409-5413.
101. Tam J.P., Zavala F. Multiple antigen peptide. A novel approach to increase detection sensitivity of synthetic peptides in solid-phase immunoassays. J Immunol Methods. 124:1989;53-61.
102. Tam J.P., Spetzler J.C. Multiple antigen peptide system. Methods Enzymol. 289:1997;612-637.
103. Kouzmitcheva G.A., Petrenko V.A., Smith G.P. Identifying diagnostic peptides for Lyme disease through epitope discovery. Clin Diag Lab Immunol. 8:2001;150-160.
104. de Carvalho Nicacio C., Williamson R.A., Parren P.W., Lundkvist A., Burton D.R., Bjorling E. Neutralizing human Fab fragments against measles virus recovered by phage display. J Virol. 76:2002;251-258.
105. Zwick M.B., Labrijn A.F., Wang M., et al. Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41. J Virol. 75:2001;10892-10905.
106. Chen X., Scala G., Quinto I., et al. Protection of rhesus macaques against disease progression from pathogenic SHIV-89.6PD by vaccination with phage-displayed HIV-1 epitopes. Nat Med. 7:2001;1225-1231.
107. Healy J.M., Murayama O., Maeda T., Yoshino K., Sekiguchi K., Kikuchi M. Peptide ligands for integrin alpha v beta 3 selected from random phage display libraries. Biochemistry. 34:1995;3948-3955.
108. Koivunen E., Wang B., Ruoslahti E. Phage libraries displaying cyclic peptides with different ring sizes ligand specificities of the RGD-directed integrins . Biotechnology. 13:1995;265-270.
109. Bruggemann M., Neuberger M.S. Strategies for expressing human antibody repertoires in transgenic mice. Immunol Today. 17:1996;391-397.
110. Mendez M.J., Green L.L., Corvalan J.R., et al. Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice. Nat Genet. 15:1997;146-156.
111. Huls G.A., Heijnen I.A., Cuomo M.E., et al. A recombinant, fully human monoclonal antibody with antitumor activity constructed from phage-displayed antibody fragments. Nat Biotechnol. 17:1999;276-281.
112. Telling G.C., Parchi P., DeArmond S.J., et al. Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science. 274:1996;2079-2082.
113. Peretz D., Williamson R.A., Kaneko K., et al. Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature. 412:2001;739-743.
114. Williamson R.A., Peretz D., Pinilla C., et al. Mapping the prion protein using recombinant antibodies. J Virol. 72:1998;9413-9418.
115. Adey N.B., Mataragnon A.H., Rider J.E., Carter J.M., Kay B.K. Characterization of phage that bind plastic from phage-displayed random peptide libraries. Gene. 156:1995;27-31.
116. Krebber C., Spada S., Desplancq D., Krebber A., Ge L., Plückthun A. Selectively-infective phage (SIP) a mechanistic dissection of a novel in vivo selection for protein-ligand interactions . J Mol Biol. 268:1997;607-618.
117. Nelson F.K., Friedman S.M., Smith G.P. Filamentous phage DNA cloning vectors a noninfective mutant with a nonpolar deletion in gene III . Virology. 108:1981;338-350.
118. Crissman J.W., Smith G.P. Gene-III protein of filamentous phages evidence for a carboxyl-terminal domain with a role in morphogenesis . Virology. 132:1984;445-455.
119. Cheong H.S., Chang J.S., Park J.M., Byun S.M. Affinity enhancement of bispecific antibody against two different epitopes in the same antigen. Biochem Biophys Res Commun. 173:1990;795-800.
120. Holliger P., Prospero T., Winter G. "Diabodies:" small bivalent, and bispecific antibody fragments . Proc Natl Acad Sci U S A. 90:1993;6444-6448.
121. Neri D., Momo M., Prospero T., Winter G. High-affinity antigen binding by chelating recombinant antibodies (CRAbs). J Mol Biol. 246:1995;367-373.
122. de Kruif J., Logtenberg T. Leucine zipper dimerized bivalent and bispecific scFv antibodies from a semi-synthetic antibody phage display library. J Biol Chem. 271:1996;7630-7634.
123. Plückthun A., Pack P. New protein engineering approaches to multivalent and bispecific antibody fragments. Immunotechnology. 3:1997;83-105.
124. Milstein C., Cuello A.C. Hybrid hybridomas and their use in immunohistochemistry. Nature. 305:1983;537-540.
125. Schott M.E., Frazier K.A., Pollock D.K., Verbanac K.M. Preparation, characterization, and in vivo biodistribution properties of synthetically cross-linked multivalent antitumor antibody fragments. Bioconjug Chem. 4:1993;153-165.
126. Hoogenboom H.R. Mix and match building manifold binding sites . Nat Biotechnol. 15:1997;125-126.
127. Whitlow M., Filpula D., Rollence M.L., Feng S.L., Wood J.F. Multivalent Fvs characterization of single-chain Fv oligomers, and preparation of a bispecific Fv . Protein Eng. 7:1994;1017-1026.
128. Zhu Z., Zapata G., Shalaby R., Snedecor B., Chen H., Carter P. High level secretion of a humanized bispecific diabody from Escherichia coli. Biotechnology (N Y). 14:1996;192-196.
129. Renner C., Jung W., Sahin U., et al. Cure of xenografted human tumors by bispecific monoclonal antibodies and human T cells. Science. 264:1994;833-835.
130. Zhu Z., Lewis G.D., Carter P. Engineering high affinity humanized anti-p185HER2/anti-CD3 bispecific F(ab′)2 for efficient lysis of p185HER2 overexpressing tumor cells. Int J Cancer. 62:1995;319-324.
131. Curnow R.T. Clinical experience with CD64-directed immunotherapy. An overview. Cancer Immunol Immunother. 45:1997;210-215.
132. Weiner L.M., Alpaugh R.K., von Mehren M. Redirected cellular cytotoxicity employing bispecific antibodies and other multifunctional binding proteins. Cancer Immunol Immunother. 45:1997;190-192.
133. Suresh M.R. Immunoassays for cancer-associated carbohydrate antigens. Semin Cancer Biol. 2:1991;367-377.
134. Petrenko V.A., Smith G.P., Gong X., Quinn T. A library of organic landscapes on filamentous phage. Protein Eng. 9:1996;797-801.
135. Petrenko V.A., Smith G.P. Phages from landscape libraries as substitute antibodies. Protein Eng. 13:2000;589-592.
136. Jermutus L., Ryabova L.A., Plückthun A. Recent advances in producing and selecting functional proteins by using cell-free translation. Curr Opin Biotechnol. 9:1998;534-548.
137. Hanes J., Plückthun A. In vitro selection methods for screening of peptide, and protein libraries. Curr Top Microbiol Immunol. 243:1999;107-122.
138. Stemmer W.P. Rapid evolution of a protein in vitro by DNA shuffling. Nature. 370:1994;389-391.
139. Cadwell R.C., Joyce G.F. Mutagenic PCR. PCR Methods Appl. 3:1994;S136-140.
140. Mattheakis L.C., Bhatt R.R., Dower W.J. An in vitro polysome display system for identifying ligands from very large peptide libraries. Proc Natl Acad Sci U S A. 91:1994;9022-9026.
141. Mattheakis L.C., Dias J.M., Dower W.J. Cell-free synthesis of peptide libraries displayed on polysomes. Methods Enzymol. 267:1996;195-207.
142. Hanes J., Plückthun A. In vitro selection, and evolution of functional proteins by using ribosome display. Proc Natl Acad Sci U S A. 94:1997;4937-4942.
143. Hanes J., Jermutus L., Weber-Bornhauser S., Bosshard H.R., Plückthun A. Ribosome display efficiently selects and evolves high-affinity antibodies in vitro from immune libraries. Proc Natl Acad Sci U S A. 95:1998;14130-14135.
144. Hanes J., Jermutus L., Schaffitzel C., Plückthun A. Comparison of Escherichia coli and rabbit reticulocyte ribosome display systems. FEBS Lett. 450:1999;105-110.
145. Soderlind E., Strandberg L., Jirholt P., et al. Recombining germline-derived CDR sequences for creating diverse single-framework antibody libraries. Nat Biotechnol. 18:2000;852-856.
146. Cambridge Antibody Technology Group on World Wide Web URL. http://www.cambrideantibody.com.
147. Dyax Corp on World Wide Web URL. http://www.dyax.com.
148. MorphoSys AG Combinatorial Biology in Drug Discovery on World Wide Web URL. http://www.morphosys.com.
149. The V Base Database of Human Antibody Genes on World Wide Web URL: http.//www.mrc-cpe.cam.ac.uk/imt-doc.
150. The Recombinant Antibody Page on World Wide Web URL. http://www.mgen.uni-heidelberg.de/SD/SdscFvSite.html.
151. Rylatt D.B., Kemp B.E., Bundesen P.G., et al. A rapid whole-blood immunoassay system. Med J Aust. 152:1990;75-77.
152. Holt L.J., Enever C., de Wildt R.M., Tomlinson I.M. The use of recombinant antibodies in proteomics. Curr Opin Biotechnol. 11:2000;445-449.
153. de Wildt R.M., Mundy C.R., Gorick B.D., Tomlinson I.M. Antibody arrays for high-throughput screening of antibody-antigen interactions. Nat Biotechnol. 18:2000;989-994.
154. Haab BB, Dunham MJ, Brown PO. Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biol 2001;2:Research0004.1-4.13.
155. Li B., Tom J.Y., Oare D., et al. Minimization of a polypeptide hormone. Science. 270:1995;1657-1660.
156. Oldenburg K.R., Loganathan D., Goldstein I.J., Schultz P.G., Gallop M.A. Peptide ligands for a sugar-binding protein isolated from a random peptide library. Proc Natl Acad Sci U S A. 89:1992;5393-5397.
157. Giebel L.B., Cass R.T., Milligan D.L., Young D.C., Arze R., Johnson C.R. Screening of cyclic peptide phage libraries identifies ligands that bind streptavidin with high affinities. Biochemistry. 34:1995;15430-15435.
158. Cwirla S.E., Balasubramanian P., Duffin D.J., et al. Peptide agonist of the thrombopoietin receptor as potent as the natural cytokine. Science. 276:1997;1696-1699.
159. Takahashi M., Fuller S.A. Production of murine hybrid-hybridomas secreting bispecific monoclonal antibodies for use in urease-based immunoassays. Clin Chem. 34:1988;1693-1696.
160. Wognum A.W., Lansdorp P.M., Eaves A.C., Krystal G. An enzyme-linked immunosorbent assay for erythropoietin using monoclonal antibodies, tetrameric immune complexes, and substrate amplification. Blood. 74:1989;622-628.
161. Tada H., Toyoda Y., Iwasa S. Bispecific antibody-producing hybrid hybridoma and its use in one-step immunoassays for human lymphotoxin. Hybridoma. 8:1989;73-83.
162. Cao Y., Christian S., Suresh M.R. Development of a bispecific monoclonal antibody as a universal immunoprobe for detecting biotinylated macromolecules. J Immunol Methods. 220:1998;85-91.
163. Allard W.J., Moran C.A., Nagel E., Collins G., Largen M.T. Antigen binding properties of highly purified bispecific antibodies. Mol Immunol. 29:1992;1219-1227.
164. Inouye K. Bispecific-Ab-based immunoassay of thyroid-stimulating hormone. Cancer Immunol Immunother. 45:1997;159-161.
165. Kontermann R.E., Martineau P., Cummings C.E., Karpas A., Allen D., Derbyshire E., Winter G. Enzyme immunoassays using bispecific diabodies. Immunotechnology. 3:1997;137-144.